Personalized PRRT improves radiation delivery to neuroendocrine tumors
Neuroendocrine cancer is exceedingly difficult to manage and unlikely to be cured, but researchers intend to slow progression of these tumors and aid survival by personalizing patient dose of peptide-receptor radionuclide ...
Jun 12, 2017
0
0